Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Beyond Air Inc's Business Segments
Beyond Air Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
1
Largest Segment
Segment
Total Revenue
$ 2
Regions Reported
-
Revenue Share by Reportable Segment - FY
- Segment100%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Segment | $ 2 | 100% |
Description of Beyond Air Inc
Beyond Air Inc. is a medical device company that aims to develop innovative solutions for respiratory care. The company focuses on delivering a variety of non-invasive medical devices for treating respiratory diseases and conditions.
The main goal of Beyond Air Inc. is to enhance patient outcomes and improve quality of life for individuals suffering from respiratory illnesses. They strive to address the unmet needs of patients and healthcare professionals by developing safe, effective, and user-friendly medical devices.
One of their key products is the LungFit™️ system, a portable and easy-to-use device that provides nitric oxide (NO) therapy. Nitric oxide is a vasodilating and antimicrobial gas that helps improve oxygenation and supports the natural immune system processes in the lungs. The LungFit™️ system delivers the accurate and controlled dose of NO to patients via a proprietary technology, providing a non-invasive treatment option for respiratory conditions like bronchiolitis and chronic obstructive pulmonary disease (COPD).
Beyond Air Inc. also offers other solutions for respiratory care, including their Nitric Oxide Generator System (NOGS™). This system is designed to generate therapeutic levels of nitric oxide gas in a safe and reliable manner. It is intended for use in hospitals, clinics, and other healthcare settings where NO therapy is required.
The company is committed to extensive research and development to continuously improve their products and develop new therapeutic solutions. They collaborate with leading medical institutions, researchers, and healthcare professionals to ensure the effectiveness and safety of their devices.
Beyond Air Inc. remains dedicated to complying with regulatory standards to receive necessary approvals for their products. They work closely with regulatory authorities to ensure legal compliance, clinical trial management, and expedited access to their devices. Their ultimate aim is to make their medical devices widely available to patients around the world, reducing the burden of respiratory diseases and improving overall respiratory health.
In addition to their commitment to medical innovation, Beyond Air Inc. prioritizes customer satisfaction and support. They provide comprehensive training and education to healthcare professionals on the use and benefits of their devices. The company also offers technical support and assistance to hospitals and clinics that use their products.
Overall, Beyond Air Inc. is a cutting-edge medical device company that is revolutionizing respiratory care. Through their innovative products, dedication to research and development, and commitment to patient well-being, they are making significant strides in improving respiratory health and transforming the way respiratory diseases are treated.
The main goal of Beyond Air Inc. is to enhance patient outcomes and improve quality of life for individuals suffering from respiratory illnesses. They strive to address the unmet needs of patients and healthcare professionals by developing safe, effective, and user-friendly medical devices.
One of their key products is the LungFit™️ system, a portable and easy-to-use device that provides nitric oxide (NO) therapy. Nitric oxide is a vasodilating and antimicrobial gas that helps improve oxygenation and supports the natural immune system processes in the lungs. The LungFit™️ system delivers the accurate and controlled dose of NO to patients via a proprietary technology, providing a non-invasive treatment option for respiratory conditions like bronchiolitis and chronic obstructive pulmonary disease (COPD).
Beyond Air Inc. also offers other solutions for respiratory care, including their Nitric Oxide Generator System (NOGS™). This system is designed to generate therapeutic levels of nitric oxide gas in a safe and reliable manner. It is intended for use in hospitals, clinics, and other healthcare settings where NO therapy is required.
The company is committed to extensive research and development to continuously improve their products and develop new therapeutic solutions. They collaborate with leading medical institutions, researchers, and healthcare professionals to ensure the effectiveness and safety of their devices.
Beyond Air Inc. remains dedicated to complying with regulatory standards to receive necessary approvals for their products. They work closely with regulatory authorities to ensure legal compliance, clinical trial management, and expedited access to their devices. Their ultimate aim is to make their medical devices widely available to patients around the world, reducing the burden of respiratory diseases and improving overall respiratory health.
In addition to their commitment to medical innovation, Beyond Air Inc. prioritizes customer satisfaction and support. They provide comprehensive training and education to healthcare professionals on the use and benefits of their devices. The company also offers technical support and assistance to hospitals and clinics that use their products.
Overall, Beyond Air Inc. is a cutting-edge medical device company that is revolutionizing respiratory care. Through their innovative products, dedication to research and development, and commitment to patient well-being, they are making significant strides in improving respiratory health and transforming the way respiratory diseases are treated.
Beyond Air, Inc. is a clinical-stage medical technology company that is focused on developing innovative therapeutic solutions that utilize nitric oxide (NO) in various forms to treat a range of serious medical conditions. Below is an extensive description of the segments, products, and services offered by Beyond Air, Inc.
Segments
1. Respiratory Health:
Beyond Air is at the forefront of developing therapies that leverage nitric oxide for respiratory diseases. This segment primarily focuses on aerosolized nitric oxide delivery systems aimed at treating conditions like asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders.
2. Oncology:
The companys research extends into oncology, where nitric oxide is investigated as a potential therapeutic agent in cancer treatment. The goal is to harness its properties to enhance the efficacy of existing cancer therapies while potentially mitigating side effects.
3. Infectious Diseases:
Another vital segment includes the use of nitric oxide in addressing respiratory infections. Beyond Airs technology aims to combat viral and bacterial pathogens, particularly in the context of respiratory illnesses, thus positioning itself as a key player in infectious disease management.
Products
1. NOtherapy™:
NOtherapy is Beyond Airs flagship product platform that utilizes a proprietary delivery system to administer nitric oxide directly to patients. This technology is designed for the treatment of respiratory diseases and holds promise for both acute and chronic conditions. The systems are adaptable for different settings, including hospitals and home care.
2. Aerosolized Nitric Oxide Devices:
These products enable the controlled and precise delivery of aerosolized nitric oxide, aimed at providing clinicians with effective treatment options. The technology focuses on optimizing the dose and ensuring safety for patients during administration.
3. Research Products:
Beyond Air offers a range of products aimed at research applications. These include nitric oxide delivery systems for preclinical and clinical trials, allowing researchers to explore the therapeutic benefits of NO across various medical fields.
4. Nitric Oxide Generators:
The company has developed generators that produce nitric oxide on demand, ensuring uninterrupted therapeutic delivery during treatment sessions. These generators are designed to be user-friendly and are adaptable for various clinical environments.
Services
1. Clinical Support Services:
Beyond Air provides comprehensive clinical support for healthcare providers utilizing its nitric oxide products. This includes training on device usage, treatment protocols, and ongoing support to ensure effective patient management.
2. Research and Development Collaboration:
The company actively engages in collaborations with research institutions, hospitals, and pharmaceutical companies to further explore and validate the applications of nitric oxide in novel therapeutic areas. These partnerships facilitate the advancement of clinical trials and studies focusing on the efficacy of Beyond Airs technologies.
3. Regulatory Support:
Guidance and assistance are provided to healthcare facilities and partners as they navigate the regulatory landscape concerning the use of nitric oxide therapies. This service aims to streamline the process of ensuring compliance with health regulations.
Conclusion
Beyond Air, Inc. combines innovative technology with a keen focus on leveraging nitric oxide’s therapeutic properties across various medical fields. Its commitment to developing cutting-edge products, supportive services, and achieving regulatory milestones places it in a unique position within the healthcare industry, particularly in respiratory health, oncology, and infectious disease markets. Through ongoing research and collaboration, Beyond Air aims to enhance the quality of care and patient outcomes in multiple therapeutic areas.
Segments
1. Respiratory Health:
Beyond Air is at the forefront of developing therapies that leverage nitric oxide for respiratory diseases. This segment primarily focuses on aerosolized nitric oxide delivery systems aimed at treating conditions like asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders.
2. Oncology:
The companys research extends into oncology, where nitric oxide is investigated as a potential therapeutic agent in cancer treatment. The goal is to harness its properties to enhance the efficacy of existing cancer therapies while potentially mitigating side effects.
3. Infectious Diseases:
Another vital segment includes the use of nitric oxide in addressing respiratory infections. Beyond Airs technology aims to combat viral and bacterial pathogens, particularly in the context of respiratory illnesses, thus positioning itself as a key player in infectious disease management.
Products
1. NOtherapy™:
NOtherapy is Beyond Airs flagship product platform that utilizes a proprietary delivery system to administer nitric oxide directly to patients. This technology is designed for the treatment of respiratory diseases and holds promise for both acute and chronic conditions. The systems are adaptable for different settings, including hospitals and home care.
2. Aerosolized Nitric Oxide Devices:
These products enable the controlled and precise delivery of aerosolized nitric oxide, aimed at providing clinicians with effective treatment options. The technology focuses on optimizing the dose and ensuring safety for patients during administration.
3. Research Products:
Beyond Air offers a range of products aimed at research applications. These include nitric oxide delivery systems for preclinical and clinical trials, allowing researchers to explore the therapeutic benefits of NO across various medical fields.
4. Nitric Oxide Generators:
The company has developed generators that produce nitric oxide on demand, ensuring uninterrupted therapeutic delivery during treatment sessions. These generators are designed to be user-friendly and are adaptable for various clinical environments.
Services
1. Clinical Support Services:
Beyond Air provides comprehensive clinical support for healthcare providers utilizing its nitric oxide products. This includes training on device usage, treatment protocols, and ongoing support to ensure effective patient management.
2. Research and Development Collaboration:
The company actively engages in collaborations with research institutions, hospitals, and pharmaceutical companies to further explore and validate the applications of nitric oxide in novel therapeutic areas. These partnerships facilitate the advancement of clinical trials and studies focusing on the efficacy of Beyond Airs technologies.
3. Regulatory Support:
Guidance and assistance are provided to healthcare facilities and partners as they navigate the regulatory landscape concerning the use of nitric oxide therapies. This service aims to streamline the process of ensuring compliance with health regulations.
Conclusion
Beyond Air, Inc. combines innovative technology with a keen focus on leveraging nitric oxide’s therapeutic properties across various medical fields. Its commitment to developing cutting-edge products, supportive services, and achieving regulatory milestones places it in a unique position within the healthcare industry, particularly in respiratory health, oncology, and infectious disease markets. Through ongoing research and collaboration, Beyond Air aims to enhance the quality of care and patient outcomes in multiple therapeutic areas.